Karen Snyder
Psychiatry · Bellaire, TXNPI 1487709788
Payments from drug & device makers
Across 132 payments — averaging $20.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$446
- Johnson & Johnson$439
- Vanda Pharmaceuticals Inc.$187
- Neurocrine Biosciences, Inc.$187
- AbbVie$174
- Takeda Pharmaceuticals U.S.A., Inc.$170
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,705100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 23 | $446 |
| Johnson & Johnson | 18 | $439 |
| Vanda Pharmaceuticals Inc. | 6 | $187 |
| Neurocrine Biosciences, Inc. | 9 | $187 |
| AbbVie(2 entities) | 9 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $170 |
| Lundbeck LLC | 12 | $169 |
| Ironshore Pharmaceuticals Inc. | 7 | $139 |
| E.r. Squibb & Sons, L.L.C. | 1 | $129 |
| Shire North American Group Inc | 7 | $118 |
| Bausch Health US, LLC | 5 | $104 |
| Jazz Pharmaceuticals Inc. | 3 | $68 |
| Adlon Therapeutics L.p. | 3 | $61 |
| Neos Therapeutics, LP | 4 | $55 |
| Rhodes Pharmaceuticals L.p. | 2 | $47 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| Tris Pharma Inc | 2 | $28 |
| Alkermes, Inc. | 1 | $24 |
| OWP Pharmaceuticals, Inc. | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Neuronetics, Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Validus Pharmaceuticals LLC | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Corium, LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$141
How this compares
$2,705 in reported general payments places this provider in the 80th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisdexamfetamine Dimesylate | 15 | $4,134 |
| Vilazodone Hcl | 11 | $2,591 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 15 | $468 |
| Bupropion XlBupropion Hcl | 15 | $324 |
| Sertraline Hcl | 13 | $257 |
| Lamotrigine | 15 | $236 |
| Trazodone Hcl | 12 | $182 |
| Topiramate | 14 | $165 |
| Zolpidem Tartrate | 13 | $44 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Bellaire
- Scott BartleyDallas$42.7M
- David BrownAustin$15.8M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
- Michael DowningDallas$7.6M
- Rakesh JainLake Jackson$7.2M
- Suresh SureddiPlano$5.9M
- Marshall LucasThe Woodlands$4.8M
- Sejal MehtaPlano$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.